Actinium Pharmaceuticals
Actinium gets Orphan Drug Designation for myeloid leukaemia drug
March 31, 2016Research and Development Actinium Pharmaceuticals
New York-based biopharma Actinium Pharmaceuticals (NYSE MKT: ATNM) has received orphan drug designation from the US FDA for Iomab-B, a …
Latest content
Highlighting the value of lab research for healthcare innovation
November 2, 2026
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
